healthcare market
Cleanroom Technology Market to Reflect Impressive Growth in Healthcare Industry
The major factors driving the growth of this market are the stringent regulatory framework, growth of the biologics sector, rising demand for sterilized pharmaceutical formulations, growing demand for medical devices, and technological advancements in cleanroom technology.
What the Market Looks Like?
Predicted to grow at a CAGR of 6.6% during the forecast period, the global Cleanroom Technology market is estimated to reach USD 7.9 billion by the end of 2024.
“By product, the consumables segment is expected to account for the largest share of the cleanroom technologies market”
The consumables segment is estimated to account for the largest market share in 2018. The large share of this segment can be attributed to the high and growing number of pharmaceutical, biotech, and medical device companies facilitating the use of disposable protective clothing.
“In the cleanroom construction market, by type, the hardwall cleanrooms segment is expected to grow at the highest CAGR during the forecast period”
The hardwall cleanrooms segment is expected to grow at the highest CAGR during the forecast period. The growth in this segment can be attributed to factors such as the higher demand for hardwall cleanrooms, as they are more design-flexible than standard and softwall cleanrooms, quick and easy to install, freestanding for easy portability, and easy to expand or reconfigure.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263122482
Geographical growth scenario of Cleanroom Technology Market
The APAC market is projected to register the highest growth during the forecast period. Factors such as the increasing healthcare expenditure and growing base of pharma companies in the country are some of the key factors driving the growth of the cleanroom technologies market in the APAC.
Leading market players
The prominent players in the Cleanroom Technology market include Azbil Corporation (Japan), Kimberly-Clark Corporation (US), Ardmac (Ireland), Clean Air Products (US), Labconco Corporation (US), Dynarex Corporation (US), DowDuPont Inc. (US), Illinois Tool Works Inc. (US), Taikisha Ltd. (Japan), Exyte AG (Germany), COLANDIS GmbH (Germany), ABN Cleanroom Technology (Belgium), Clean Rooms International, Inc. (US), Bouygues Group (France), Terra Universal, Inc. (US), Connect 2 Cleanrooms Ltd (UK), Camfil (Sweden), OCTANORM-Vertriebs-GmbH (Germany), Parteco Srl (Italy), and Airtech Japan, Ltd. (Japan).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=263122482
Cell Counting Market to Reflect Impressive Growth in Healthcare Industry
The major factors driving the growth of this market include the growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.
What the Market Looks Like?
Predicted to grow at a CAGR of 6.8% during the forecast period, the global Cell Counting market is estimated to reach USD 12.32 billion by the end of 2023.
“By product, the consumables segment is expected to account for the largest share of the cell counting market in 2018”
On the basis of product, the consumables segment is expected to account for the largest share of the global cell counting market in 2018. This large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures.
“By application, the research applications segment is estimated to hold the largest share in 2018”
Based on application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. In 2018, the research applications segment is expected to account for the largest share of the cell counting market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728
Geographical growth scenario of Cell Counting Market
North America is expected to account for the largest share of the cell counting market in 2018, followed by Europe and Asia Pacific. The growing incidence rate of various infectious diseases, investment initiatives by the government, and presence of high-quality infrastructure for clinical and laboratory research are the major factors responsible for the large share of the North American cell counting market.
Leading market players
The prominent players in the Cell Counting market include Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Agilent Technologies (US), BioTek Instruments (US), Tecan Group (Switzerland), Roche Diagnostics (Switzerland), Sysmex Corporation (Japan), HORIBA, Ltd. (Japan), Abbott Laboratories (US), and Siemens Healthineers (Germany).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728
Electrophoresis Market to Reflect Impressive Growth in Healthcare Industry
The major factors that are expected to be driving the electrophoresis market are growth in funding for research on electrophoresis techniques, increasing number of research collaborations between market players and academic institutions, increasing use of capillary electrophoresis (CE) with mass spectroscopy (MS), and growing focus on next-generation sequencing research are driving the growth of the electrophoresis market.
What the Market Looks Like?
Predicted to grow at a CAGR of 5.4% during the forecast period, the global Electrophoresis market is estimated to reach USD 2,796.1 million by the end of 2022.
“Gel documentation systems segment is expected to register the highest CAGR during the forecast period.”
On the basis of product, the electrophoresis market is segmented into electrophoresis reagents, electrophoresis systems, gel documentation systems, and software. The gel documentation systems segment is expected to register the highest CAGR during the forecast period.
“Hospitals & diagnostic centers are expected to grow at the highest CAGR during 2017 to 2022.”
Based on end user, the electrophoresis market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and other end users. The hospitals & diagnostic centers segment is expected to grow at the highest CAGR during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=434
Geographical growth scenario of Electrophoresis Market
North America held the largest share of the global electrophoresis market in 2016. On the other hand, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period, owing to the growing proteomics and genomics research & increasing research funding, rising adoption of advanced electrophoresis techniques, increasing investments by pharmaceutical and biotechnology companies, and growing research collaborations and funding.
Leading market players
The prominent players in the Electrophoresis market Bio-Rad Laboratories (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=434
Advanced Visualization Market to Reflect Impressive Growth in Healthcare Industry
The factors driving market growth include technological advancements in AV software such as integration of PACS & AV tools, improved diagnostic interpretation with AV tools, rising prevalence of target diseases, and growing demand for advanced diagnostic procedures.
What the Market Looks Like?
Predicted to grow at a CAGR of 11.0% during the forecast period, the global Advanced Visualization market is estimated to reach USD 3.19 Billion by the end of 2021.
“Hysteroscopes expected to dominate the market in 2017”
Based on type, the Advanced Visualization market is segmented into handheld instruments, hysteroscopes, resectoscopes, hysterosheaths, fluid management systems, and tissue removal systems. In 2017, the hysteroscopes segment is expected to account for the largest share of the Advanced Visualization market.
“Based on applications, the diagnostic hysteroscopy segment is projected to grow at the highest CAGR during the forecast period.”
By applications, the Advanced Visualization market is segmented into diagnostic hysteroscopy and operative hysteroscopy. The diagnostic hysteroscopy segment is expected to grow at the highest rate during the forecast period. The increasing incidence of uterine abnormalities is a major factor driving the demand for diagnostic hysteroscopy.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=111936030
Geographical growth scenario of Advanced Visualization Market
On the basis of region, the advanced visualization market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the market. Dominant position of North America in advanced visualization industry is attributed to the faster adoption of novel diagnostic imaging technologies (as compared to other regions), advancements in the field of advanced visualization technologies, large number of disease diagnostic procedures, and higher preference for advanced visualization solutions for diagnostic imaging.
Leading market players
The prominent players in the Advanced Visualization market include General Electric Company (U.S.), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Toshiba Corporation (Japan), Terarecon, Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Pro Medicus Limited (Australia), Carestream Health, Inc. (U.S.), Agfa-Geveart N.V. (Belgium), and Qi Imaging, LLC (U.S.), among others.
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=111936030
Urinalysis Market to Reflect Impressive Growth in Healthcare Industry
Market growth is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis.
What the Market Looks Like?
Predicted to grow at a CAGR of 7.6% during the forecast period, the global Urinalysis market is estimated to reach USD 4.6 billion by the end of 2024.
“Pregnancy and fertility tests to dominate the urinalysis market in 2019.”
On the basis of test type, the urinalysis market is segmented into biochemical urinalysis, sediment urinalysis, and pregnancy & fertility tests. In 2019, pregnancy & fertility tests are expected to account for the largest market share. Growing use of these kits in home care settings is driving the growth of this segment.
“Hospitals & clinics expected to dominate the urinalysis market in 2019.”
By end user, the urinalysis market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, and research laboratories & institutes. In 2019, hospitals & clinics are expected to account for the largest share of 40% of the market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294
Geographical growth scenario of Urinalysis Market
On the basis of region, the urinalysis market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the urinalysis market. The large share of this market segment can be attributed to the increasing incidence of chronic kidney diseases and UTIs as well as the increasing adoption of technologically advanced automated devices in the region.
Leading market players
The prominent players in the Urinalysis market include Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc. (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Biorad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294
Hysteroscopy Instruments Market to Reflect Impressive Growth in Healthcare Industry
The growth of the market is attributed to the growth in female geriatric population and the rising incidence of gynecological diseases; increasing adoption of minimally invasive treatments; implementation of favorable government initiatives and the increasing adoption of office hysteroscopy.
What the Market Looks Like?
Predicted to grow at a CAGR of 7.8% during the forecast period, the global Hysteroscopy Instruments market is estimated to reach USD 1.89 Billion by the end of 2022.
“Hysteroscopes expected to dominate the market in 2017”
Based on type, the hysteroscopy instruments market is segmented into handheld instruments, hysteroscopes, resectoscopes, hysterosheaths, fluid management systems, and tissue removal systems. In 2017, the hysteroscopes segment is expected to account for the largest share of the hysteroscopy instruments market.
“Based on applications, the diagnostic hysteroscopy segment is projected to grow at the highest CAGR during the forecast period.”
By applications, the hysteroscopy instruments market is segmented into diagnostic hysteroscopy and operative hysteroscopy. The diagnostic hysteroscopy segment is expected to grow at the highest rate during the forecast period. The increasing incidence of uterine abnormalities is a major factor driving the demand for diagnostic hysteroscopy.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219885903
Geographical growth scenario of Hysteroscopy Instruments Market
In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as technological innovations, increasing healthcare spending, government initiatives to create awareness regarding women’s health, and increasing incidence of gynecological diseases.
Leading market players
The prominent players in the Hysteroscopy Instruments market include KARL STORZ (Germany), Olympus (Japan), Richard Wolf (Germany), Stryker (US), Hologic (US), Medtronic (Ireland), Ethicon (Scotland), B. Braun (Germany), Boston Scientific (US), MedGyn Products (US), CooperSurgical (US) , Cook Medical (US), Medicon (Germany), Maxer Medizintechnik (Germany), and Hospiline Equipments (India).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=219885903
Indian Heparin Market to Reflect Impressive Growth in Healthcare Industry
Increasing prevalence of chronic diseases such as cancer and diabetes and favorable government policies for the pharmaceutical sector are the major factors driving the growth of Indian peptide market.
What the Market Looks Like?
Predicted to grow at a CAGR of 4.9% during the forecast period, the global Indian Heparin market is estimated to reach USD 170.2 Million by the end of 2022.
“By type, hormonal segment is expected to dominate the market in 2016”
On the basis of type segmentation, The Indian peptide drugs market is classified into hormonal, antifungal, antibiotic, ACE inhibitor and others. The hormonal segment is expected to dominate the Indian peptide drugs market in 2016.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77044734
“By application, the diabetes segment is expected to dominate the market in 2016”
Based on application, the indian peptide drugs market is segmented into diabetes, infectious disease, cancer, cardiology, osteoporosis, gynecological application, and other applications. In 2016, the diabetes segment is expected to account for the largest share of the Indian peptide drugs market, by application.
Leading market players
The prominent players in the Indian Heparin market include Abbott Laboratories (US), Sanofi S.A. (France), Eli Lilly and Company (U.S.), Cipla Limited (India), Biocon Limited (India), Intas Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Cadila Pharmaceuticals (India), Lupin Limited (India), Emcure Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Dr. Reddy’s Laboratories Limited (India), and Alkem Laboratories Limited (India).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=77044734
Live Cell Imaging Market to Reflect Impressive Growth in Healthcare Industry
The growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research are the major factors driving the growth of the global live cell imaging market.
What the Market Looks Like?
Predicted to grow at a CAGR of 8.9% during the forecast period, the global Live Cell Imaging market is estimated to reach USD 2.9 billion by the end of 2023.
“The instruments segment accounted for the largest share of the market in 2018”
On the basis of product and service, the global live cell imaging market is segmented into instruments, consumables, software, and services. In 2018, the instruments segment accounted for the largest share of the live cell imaging market.
“The academic & research institutes segment is expected to grow at the highest CAGR during the forecast period”
On the basis of end user, the live cell imaging market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). The academic & research institutes segment is expected to grow at a higher CAGR during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163914483
Geographical growth scenario of Live Cell Imaging Market
North America is expected to dominate the live cell imaging market in 2018. The large share of the North America live cell imaging market can primarily be attributed to the availability of government funding for life science research, drug development regulations, advances in live cell imaging techniques, growth in the biotechnology and pharmaceutical industries, and the rising incidence of cancer.
Leading market players
The prominent players in the Live Cell Imaging market include Danaher Corporation (US), Carl Zeiss AG (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer, Inc. (US), GE Healthcare (US), Bruker Corporation (US), Thermo Fisher Scientific Inc. (US), Sartorius AG (Germany), BioTek Instruments (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), and NanoEnTek Inc. (Korea).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=163914483
Hearing Aids Market to Reflect Impressive Growth in Healthcare Industry
The growth of this market is majorly attributed to the high prevalence of hearing loss, rising geriatric population, and technological advancements in hearing aids.
What the Market Looks Like?
Predicted to grow at a CAGR of 7.0% during the forecast period, the global Hearing Aids market is estimated to reach USD 9.78 Billion by the end of 2022.
“Hearing aid devices segment to dominate the market in 2017”
Based on product, the hearing aids market is segmented into hearing aid devices and hearing implants. In 2017, the hearing aid devices segment is expected to account for the largest share of the hearing aids market.
“The adult patients segment is projected to register the highest CAGR during the forecast period.”
By patient type, the hearing aid market is segmented into adult patients and pediatric patients. The adult patients segment is estimated to register the highest growth rate during the forecast period. The high growth in this segment can primarily be attributed to the high prevalence of hearing loss in this section of the population.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198630754
Geographical growth scenario of Hearing Aids Market
In 2017, Europe is expected to dominate the global market primarily due to factors such as the growing aging population and high prevalence of hearing loss in this region. In 2017, North America is expected to account for the second-largest share of this market.
Leading market players
The prominent players in the Hearing Aids market include Sonova (Switzerland), William Demant (Denmark), GN Store Nord (Denmark), Cochlear (Australia), Starkey (US), Widex (Denmark), MED-EL (Austria), SeboTek Hearing Systems (US), Audina Hearing Instruments (US), RION (Japan), Horentek (Italy), Microson (Spain), and Arphi Electronics (India).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=198630754
Veterinary CT Scanner Market to Reflect Impressive Growth in Healthcare Industry
The key factors driving the growth of this market include the increasing small companion animal population, growing pet adoption, rising demand for pet insurance with growing animal health expenditure, growing number of veterinary practitioners and their income levels in developed economies, and innovation in veterinary CT scanners.
What the Market Looks Like?
Predicted to grow at a CAGR of 7.3% during the forecast period, the global Veterinary CT Scanner market is estimated to reach USD 173.7 Million by the end of 2022.
“By type, the stationary multi-slice CT scanners segment accounted for the largest share of the market in 2016”
On the basis of type, the veterinary CT scanner market is broadly segmented into stationary multi- slice CT scanners and portable CT scanners. In 2016, the stationary multi-slice CT scanners segment accounted for the largest share of this market.
“By animal type, small companion animals accounted for the largest share of this market in 2016”
On the basis of animal type, the veterinary CT scanner market is further segmented into small companion animals, equine and livestock, and other animals. In 2016, the small companion animals segment held the largest share of this market and is expected to grow at the highest CAGR during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39631288
Geographical growth scenario of Veterinary CT Scanner Market
North America accounted for the largest share of the veterinary CT scanner market in 2016, followed by Europe and Asia Pacific. The largest share of this region is mainly attributed to the increasing adoption of pet animals, the growing pet insurance industry, and rising veterinary healthcare expenditure in the region.
Leading market players
The prominent players in the Veterinary CT Scanner market include GE Healthcare (US), Canon, Inc. (Toshiba Medical Systems Corporation) (Japan), Siemens AG (Siemens Healthineers) (Germany), Samsung Electronics Co. Ltd. (NeuroLogica Corporation) (South Korea), Epica Medical Innovation (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Animage, LLC (US), GIN ApS (Denmark), QR s.r.l. (Italy), and 4DDI (US).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=39631288
US Veterinary Infusion Pumps Market to Reflect Impressive Growth in Healthcare Industry
Growth in this market is majorly attributed to factors such as increasing demand for pet insurance and rising animal healthcare expenditure, growing demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels.
What the Market Looks Like?
Predicted to grow at a CAGR of 5.8% during the forecast period, the global US Veterinary Infusion Pumps market is estimated to reach USD 35.4 Million by the end of 2021.
“Large-volume infusion pumps account for the largest share of the U.S. veterinary infusion pumps market”
Large-volume infusion pumps account for the largest share of the U.S. veterinary infusion pumps market and are expected to witness the highest growth over the next five years. The high growth in this segment can be attributed to the growing use of these pumps to deliver large volumes of fluids in animals during emergency conditions, provide blood transfusions, and administer total parenteral nutrition at continuous predetermined medium-to-high flow rates.
“Private hospitals accounted for the largest share”
In the end-user market, private hospitals accounted for the largest share, majorly due to the increasing use of large-volume infusion pumps and syringe infusion pumps to administer fluids for various clinical conditions in animals, and growth in animal health expenditure.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160422967
Leading market players
The prominent players in the US Veterinary Infusion Pumps market include Heska Corporation (U.S.), Digicare Biomedical Technology Inc. (U.S.), B. Braun Melsungen AG (Germany), Q Core Medical Ltd. (Israel), Grady Medical System Inc. (U.S.), Mediaid Inc. (U.S.), Burtons Medical Equipment Ltd. (U.K.), Jørgen Kruuse A/S (Denmark), and Kent Scientific Corporation (U.S.).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=160422967
Healthcare Fraud Analytics Market to Reflect Impressive Growth in Healthcare Industry
Market growth can be attributed to the large number of fraudulent activities in healthcare; the increasing number of patients seeking health insurance; high returns on investment; and rising pharmacy claim-related frauds. However, the dearth of skilled personnel is likely to restrain the growth of this market.
What the Market Looks Like?
Predicted to grow at a CAGR of 29.8% during the forecast period, the global Healthcare Fraud Analytics market is estimated to reach USD 4.6 billion by the end of 2025.
“The prescriptive analytics segment registered the highest growth during the forecast period.”
Fraud analytics solutions vary from vendor to vendor. Some vendors offer rule-based models while others offer AI-based technologies, but broadly, these solutions are classified based on the type of analytics used—descriptive analytics, predictive analytics, and prescriptive analytics.
“In 2019, public & government agencies accounted for the largest share of the healthcare fraud analytics market, by end user.”
Based on end user, the healthcare fraud detection market is segmented into public & government agencies, private insurance payers, employers, and third-party service providers. The public & government agencies segment accounted for the largest share of the healthcare fraud analytics market in 2019.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221837663
Geographical growth scenario of Healthcare Fraud Analytics Market
Geographically, the global healthcare fraud analytics market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America accounted for the largest share of the market in 2019.
Leading market players
The prominent players in the Healthcare Fraud Analytics market include IBM Corporation (US), Optum (US), SAS Institute (US), Change Healthcare (US), EXL Service Holdings (US), Cotiviti (US), Wipro Limited (Wipro) (India), Conduent (US), HCL (India), Canadian Global Information Technology Group (Canada), DXC Technology Company (US), Northrop Grumman Corporation (US), LexisNexis Group (US), and Pondera Solutions (US).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=221837663
Healthcare Asset Management Market to Reflect Impressive Growth in Healthcare Industry
The growth of the healthcare asset management market is driven by need for better asset management in hospitals, acceptance of asset management solutions in the pharmaceutical industry, and decline in prices of RFID Tags.
What the Market Looks Like?
Predicted to grow at a CAGR of 6.2% during the forecast period, the global Healthcare Asset Management market is estimated to reach USD 2.5 billion by the end of 2022.
“RFID Tags segment is expected to dominate the RFID products market in 2018.”
Based on type, the healthcare asset management market is segmented into tags, readers/interrogators, antennas, and accessories. In 2018, the RFID tags segment is expected to dominate the market. The growth of this market is attributed to the increasing acceptance of RFID in pharmaceutical companies, declining prices of RFID tags, and the availability of technologically advanced products in the market.
“Based on type, the passive RFID tag segment is projected to grow at the highest CAGR during the forecast period.”
Based on type, RFID tags market is segmented into passive tags and active tags. In 2018, the passive RFID segment is expected to account for the largest share of the market; also, this segment is expected to register highest CAGR during the forecast period owing to the low cost of passive tags in comparison with active tags. Also, passive tags do not require an external source of energy, owing to which they are more widely adopted.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1195
Geographical growth scenario of Healthcare Asset Management Market
In 2018, North America is expected to dominate the market followed by Europe. The large share of this region is attributed to factors such as growing patient safety concerns, acceptance of healthcare asset management solutions in hospitals, increasing need to tackle drug counterfeiting, technologically advanced products, and the presence of key players in the region.
Leading market players
The prominent players in the Healthcare Asset Management market include AiRISTA Flow (US), Elpas (US), CenTrak, Inc.(US), ThingMagic [A Novanta Company (US], Sonitor (Norway), Stanley Healthcare (US), Versus Technology, Inc. (US), Zebra Technologies (US), GE Healthcare (US), and IBM Corporation (US).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1195
Dairy Herd Management Market to Reflect Impressive Growth in Healthcare Industry
Growing herd sizes, the rising production & consumption of milk & dairy products, increasing investments in dairy farm development, and technological advancements in management systems have all played a significant role in driving market growth.
What the Market Looks Like?
Predicted to grow at a CAGR of 5.7% during the forecast period, the global Dairy Herd Management market is estimated to reach USD 20.25 Billion by the end of 2021.
“Automated systems held the largest share of the dairy herd management products market in 2017”
The market, by product, is segmented into automated systems and standalone software. Automated systems dominated the market in 2017. This is largely due to the increasing mechanization in dairy farming (caused by a dearth of labor), growing preference for automated systems, and the rising demand for dairy products.
“The large-scale dairy farms segment is expected to grow at the highest rate in the end-user market”
Based on the end-user, the dairy herd management market is segmented into small-scale, large-scale, and cooperative dairy farms. The large-scale dairy farms segment is projected to show the highest growth between 2017 and 2022.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36572220
Geographical growth scenario of Dairy Herd Management Market
The regional segments of the market are North America, Europe, the Asia Pacific, and the Rest of the World (RoW). Europe—characterized by a growing demand for high-quality dairy products, a strong dairy industry, and high production volumes—held the largest share of the dairy herd management market in 2017.
Leading market players
The prominent players in the Dairy Herd Management market include Delaval (Sweden), GEA Group (Germany), Afimilk (Israel), BouMatic (US), Fullwood (UK), Dairy Master (Ireland), Lely Holdings (Netherlands), SCR Dairy (Israel), Sum-It Computer Systems (UK), and VAS (US)
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=36572220
Asia-Pacific Animal Health Market to Reflect Impressive Growth in Healthcare Industry
Growth in this market can majorly be attributed to factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of animal disease outbreaks.
What the Market Looks Like?
Predicted to grow at a CAGR of 5.7% during the forecast period, the global Asia-Pacific Animal Health market is estimated to reach USD 20.25 Billion by the end of 2021.
“Growth promoters accounted for the largest share of the market in 2015”
The market is segmented into growth promoters, feed additives, vaccines, parasiticides, antimicrobials and antibiotics, and other pharmaceuticals. Growth promoters accounted for the largest share of the market in 2015 owing to its wide utilization by livestock producers and pet owners.
“The Asia pacific animal Health market is segmented into food-producing animals and companion animals.”
The market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest share of the market, while companion animals are expected to register the highest growth during the forecast period.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485
Geographical growth scenario of Asia-Pacific Animal Health Market
China is the largest regional segment for the APAC animal health market and is expected to witness the highest growth rate during the forecast period. The large share of this regional segment is driven by the increasing livestock population, rising demand for animal-derived food products in China, increasing pet ownership, and growing adoption of pet insurance.
Leading market players
The prominent players in the Asia-Pacific Animal Health market include Zoetis, Inc. (U.S.), Eli Lilly and Company (U.S.), Sanofi (France), Merck and Co., Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), Bayer AG (Germany), Virbac (France), Ceva Santé Animale (France), Vetoquinol S.A. (France), Cargill, Inc. (U.S.), Royal DSM N.V. (Netherlands), and Perrigo Company Plc (U.S.).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=106215485
ELISpot and FluoroSpot Assay System Market to Reflect Impressive Growth in Healthcare Industry
Growth in this market is largely driven by the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers.
What the Market Looks Like?
Predicted to grow at a CAGR of 16.2% during the forecast period, the global ELISpot and FluoroSpot Assay System market is estimated to reach USD 287 million by the end of 2023.
“Assay kits are projected to dominate the ELISpot and FluoroSpot market in 2018”
By product type, the ELISpot and FluoroSpot market is segmented into assay kits, analyzers, and ancillary products. The assay kits are further subsegmented by utility, type, and analyte. In 2018, the assay kits segment is expected to account for the largest share of the market. The rising incidence of chronic diseases and technological advancements are driving the growth of this product segment.
“Diagnostic applications to hold the largest share of the market in 2018”
Based on the applications, the ELISpot and FluoroSpot market is segmented into diagnostic and research applications. In 2018, the diagnostic applications segment is expected to account for the larger share of the ELISpot and FluoroSpot market in 2018. The large share of this segment can be attributed to the rising global prevalence of infectious diseases and the increasing use of ELISpot kits for disease diagnosis.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584
Geographical growth scenario of ELISpot and FluoroSpot Assay System Market
North America is expected to command the largest share of the ELISpot and FluoroSpot market. The large share of this regional segment can be attributed to the increasing incidence of chronic diseases. In addition to this, the increasing focus on vaccine development is driving the growth of this market.
Leading market players
The prominent players in the ELISpot and FluoroSpot Assay System market include Oxford Immunotec (UK), Cellular Technologies (US), Mabtech (Sweden), Becton, Dickinson and Company (US), Abcam (UK), Bio-Techne (US), Autoimmun Diagnostika (Germany), Biotech Investissement (France), Lophius Biosciences (Germany), and U-CyTech (Netherlands).
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=124350584
